From: Hepatic steatosis in women with polycystic ovary syndrome
 | Non-NAFLD N(%) | NAFLD N(%) | P |
---|---|---|---|
Central obesity | 47 (35.3%) | 62 (88.6%) | < 0.001 |
Increased blood pressure | 8 (17.4%) | 19 (52.8%) | 0.001 |
Hypertriglyceridemia | 13 (9.1%) | 27 (37.5%) | < 0.001 |
Hyperlipidemia | 47 (32.9%) | 42 (58.3%) | < 0.001 |
Abnormal blood glucose | 24 (16.9%) | 30 (41.7%) | < 0.001 |
HOMA-IR ≥ 3.54 | 5 (3.6%) | 56 (81.2%) | < 0.001 |
Metabolic syndrome | 1 (0.7%) | 35 (47.9%) | < 0.001 |
Abnormal liver enzymes | 5 (3.5%) | 23 (31.5%) | < 0.001 |
ALT ≥ 18.2 | 42 (29.2%) | 54 (74.0%) | < 0.001 |
FAI > 8 | 36 (28.6%) | 42 (68.9%) | < 0.001 |
Hirsutism | 42 (30.0%) | 28 (38.9%) | 0.964 |
Acne | 68 (48.2%) | 31 (43.1%) | 0.674 |
PCOM | 114 (88.4%) | 60 (95.2%) | 0.124 |